Disparities in the management of cutaneous malignant melanoma. A population-based high-resolution study

被引:9
作者
Guevara, Marcela [1 ,2 ]
Rodriguez-Barranco, Miguel [2 ,3 ]
Puigdemont, Montse [4 ,5 ]
Minicozzi, Pamela [6 ]
Yanguas-Bayona, Ignacio [7 ]
Porras-Povedano, Miguel [8 ]
Rubio-Casadevall, Jordi [9 ]
Sanchez Perez, Maria Jose [2 ,3 ]
Marcos-Gragera, Rafael [2 ,4 ,5 ]
Ardanaz, Eva [1 ,2 ]
机构
[1] Navarra Publ Hlth Inst IdiSNA, Pamplona, Spain
[2] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain
[3] Univ Granada, Biomed Res Inst Granada Ibs Granada, Andalusian Sch Publ Hlth, Granada, Spain
[4] Catalan Inst Oncol, IdIbGi, Descript Epidemiol Genet & Canc Prevent Grp, Epidemiol Unit, Girona, Spain
[5] Catalan Inst Oncol, IdIbGi, Descript Epidemiol Genet & Canc Prevent Grp, Girona Canc Registry, Girona, Spain
[6] Fdn IRCCS Ist Nazl Tumori Milano, Res Dept, Analyt Epidemiol & Hlth Impact Unit, Milan, Italy
[7] Navarra Hosp Complex IdiSNA, Dermatol Dept, Pamplona, Spain
[8] Serv Andaluz Salud, Area Gest Sanitaria Osuna, Seville, Spain
[9] Univ Girona, Catalan Inst Oncol, Med Oncol Dept, Descript Epidemiol Genet & Canc Prevent Grp,IdIbG, Girona, Spain
关键词
cancer care; clinical practice guidelines; cutaneous melanoma; geographic variation; guideline-adherence; healthcare disparities; imaging; pathology reporting; population-based cancer registries; sentinel lymph node biopsy; CLINICAL-PRACTICE GUIDELINES; SENTINEL-NODE BIOPSY; CANCER SURVIVAL; STAGE MELANOMA; DIAGNOSIS; QUALITY;
D O I
10.1111/ecc.13043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Population-based cancer registry data from three Spanish areas were used to assess the patterns of care and adherence to guidelines for cutaneous malignant melanoma. We included 934 cases diagnosed in 2009-2013. Completeness of the pathology reports, imaging for detecting distant metastasis and the use of sentinel lymph node biopsy (SLNB) were analysed. The proportion of pathology reports that mentioned the essential pathological features required for T staging was 93%, ranging across geographic areas from 81% to 98% (p < 0.001). The percentage of low-risk patients who underwent no imaging studies, as proposed by guidelines, or only chest imaging ranged among areas from 0.6% to 84% (p < 0.001). Of the patients with clinically node-negative melanoma >1 mm thick and no distant metastases, 68% underwent SLNB, varying by area from 61% to 78% (p = 0.017). This study revealed wide geographic variation in different aspects of melanoma care. The use of a standardised structured pathology report could strengthen the completeness of reporting. Improvement strategies should also include efforts to reduce overuse of imaging in low-risk patients and to increase the adherence to guidelines recommendations on the use of SLNB.
引用
收藏
页数:10
相关论文
共 37 条
  • [1] Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
    Allemani, Claudia
    Matsuda, Tomohiro
    Di Carlo, Veronica
    Harewood, Rhea
    Matz, Melissa
    Niksic, Maja
    Bonaventure, Audrey
    Valkov, Mikhail
    Johnson, Christopher J.
    Esteve, Jacques
    Ogunbiyi, Olufemi J.
    Azevedo e Silva, Gulnar
    Chen, Wan-Qing
    Eser, Sultan
    Engholm, Gerda
    Stiller, Charles A.
    Monnereau, Alain
    Woods, Ryan R.
    Visser, Otto
    Lim, Gek Hsiang
    Aitken, Joanne
    Weir, Hannah K.
    Coleman, Michel P.
    [J]. LANCET, 2018, 391 (10125) : 1023 - 1075
  • [2] [Anonymous], 2018, NCCN Clinical Practice Guidelines in Oncology
  • [3] [Anonymous], 2011, TNM CLASSIFICATION M
  • [4] [Anonymous], 2013, International Classification of Diseases for Oncology
  • [5] [Anonymous], NCCN CLIN PRACT GUID
  • [6] Final Version of 2009 AJCC Melanoma Staging and Classification
    Balch, Charles M.
    Gershenwald, Jeffrey E.
    Soong, Seng-jaw
    Thompson, John F.
    Atkins, Michael B.
    Byrd, David R.
    Buzaid, Antonio C.
    Cochran, Alistair J.
    Coit, Daniel G.
    Ding, Shouluan
    Eggermont, Alexander M.
    Flaherty, Keith T.
    Gimotty, Phyllis A.
    Kirkwood, John M.
    McMasters, Kelly M.
    Mihm, Martin C., Jr.
    Morton, Donald L.
    Ross, Merrick I.
    Sober, Arthur J.
    Sondak, Vernon K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6199 - 6206
  • [7] Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines Who Is at Risk?
    Blakely, Andrew M.
    Comissiong, Danielle S.
    Vezeridis, Michael P.
    Miner, Thomas J.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (08): : 754 - 759
  • [8] Cancer survival in adult patients in Spain. Results from nine population-based cancer registries
    Chirlaque, M. D.
    Salmeron, D.
    Galceran, J.
    Ameijide, A.
    Mateos, A.
    Torrella, A.
    Jimenez, R.
    Larranaga, N.
    Marcos-Gragera, R.
    Ardanaz, E.
    Sant, M.
    Minicozzi, P.
    Navarro, C.
    Sanchez, M. J.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (02) : 201 - 211
  • [9] Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
    Dummer, R.
    Hauschild, A.
    Lindenblatt, N.
    Pentheroudakis, G.
    Keilholz, U.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : V126 - V132
  • [10] Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Dummer, R.
    Hauschild, A.
    Guggenheim, M.
    Keilholz, U.
    Pentheroudakis, G.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 86 - 91